The evidence for the importance of IGF1 signalling in cancers was obtained in a study showing that IGF-1 binding to IGF-1R and the downregulation of this receptor are similarly efficient in the inhibition of RCC cell lines’ growth [141,142]. This evidence concerns the gene IGF1 and renal cell adenocarcinoma.